These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 21796730)

  • 1. Mutation nomenclature in practice: findings and recommendations from the cystic fibrosis external quality assessment scheme.
    Berwouts S; Morris MA; Girodon E; Schwarz M; Stuhrmann M; Dequeker E
    Hum Mutat; 2011 Nov; 32(11):1197-203. PubMed ID: 21796730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and use of a synthetic quality control material, included in the European external quality assessment scheme for cystic fibrosis.
    Berwouts S; Gordon JT; Rundell CA; Barton DE; Dequeker E
    Hum Mutat; 2008 Aug; 29(8):1063-70. PubMed ID: 18470946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of CFTR gene mutation testing methods in 136 diagnostic laboratories: report of a large European external quality assessment.
    Dequeker E; Cassiman JJ
    Eur J Hum Genet; 1998; 6(2):165-75. PubMed ID: 9781062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic testing and quality control in diagnostic laboratories.
    Dequeker E; Cassiman JJ
    Nat Genet; 2000 Jul; 25(3):259-60. PubMed ID: 10888869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's in a Name? A Coordinated Approach toward the Correct Use of a Uniform Nomenclature to Improve Patient Reports and Databases.
    Tack V; Deans ZC; Wolstenholme N; Patton S; Dequeker EM
    Hum Mutat; 2016 Jun; 37(6):570-5. PubMed ID: 26920083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Describing structural changes by extending HGVS sequence variation nomenclature.
    Taschner PE; den Dunnen JT
    Hum Mutat; 2011 May; 32(5):507-11. PubMed ID: 21309030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HGVS Nomenclature in Practice: An Example from the United Kingdom National External Quality Assessment Scheme.
    Deans ZC; Fairley JA; den Dunnen JT; Clark C
    Hum Mutat; 2016 Jun; 37(6):576-8. PubMed ID: 26919400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations and sequence variations detected in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: a report from the Cystic Fibrosis Genetic Analysis Consortium.
    Tsui LC
    Hum Mutat; 1992; 1(3):197-203. PubMed ID: 1284534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standard mutation nomenclature in molecular diagnostics: practical and educational challenges.
    Ogino S; Gulley ML; den Dunnen JT; Wilson RB;
    J Mol Diagn; 2007 Feb; 9(1):1-6. PubMed ID: 17251329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel de novo large deletion in cystic fibrosis transmembrane conductance regulator gene results in a severe cystic fibrosis phenotype.
    Norek A; Stremska M; Sobczyńska-Tomaszewska A; Wertheim-Tysarowska K; Dmeńska H; Jurek M
    J Pediatr; 2011 Aug; 159(2):343-6.e1. PubMed ID: 21663921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance regulator gene.
    Brugnon F; Bilan F; Heraud MC; Grizard G; Janny L; Creveaux I
    Fertil Steril; 2008 Nov; 90(5):2004.e23-6. PubMed ID: 18703181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction to molecular cystic fibrosis testing.
    Uphoff TS; Highsmith WE
    Clin Lab Sci; 2006; 19(1):24-31. PubMed ID: 16617555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The example of cystic fibrosis to highlight the complexity of genetic screening].
    Bochud M; Fellmann F; Vader JP; Grosse S; Paccaud F; Guessous I
    Rev Med Suisse; 2010 Jul; 6(256):1395-9. PubMed ID: 20701015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of mutations and genotype-phenotype correlation in cystic fibrosis: experience from India.
    Shastri SS; Kabra M; Kabra SK; Pandey RM; Menon PS
    J Cyst Fibros; 2008 Mar; 7(2):110-5. PubMed ID: 17716958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying CFTR molecular genetics to facilitate the diagnosis of cystic fibrosis through screening.
    Bobadilla JL; Farrell MH; Farrell PM
    Adv Pediatr; 2002; 49():131-90. PubMed ID: 12214770
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for mutations in the cystic fibrosis transmembrane regulator gene in an infertility clinic.
    Slostad J; Stein QP; Flanagan JD; Hansen KA
    Fertil Steril; 2007 Dec; 88(6):1687-8. PubMed ID: 17482604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiallelic synthetic quality control material: lessons learned from the cystic fibrosis external quality assessment scheme.
    Berwouts S; Christensen TM; Brandon J; Bejjani BA; Barton DE; Dequeker E
    Genet Test Mol Biomarkers; 2011 Sep; 15(9):579-86. PubMed ID: 21476898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular diagnosis of cystic fibrosis.
    Shrimpton AE
    Expert Rev Mol Diagn; 2002 May; 2(3):240-56. PubMed ID: 12050863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for quality improvement in genetic testing for cystic fibrosis. European Concerted Action on Cystic Fibrosis.
    Dequeker E; Cuppens H; Dodge J; Estivill X; Goossens M; Pignatti PF; Scheffer H; Schwartz M; Schwarz M; Tümmler B; Cassiman JJ
    Eur J Hum Genet; 2000 Sep; 8 Suppl 2():S2-24. PubMed ID: 11108532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical phenotype of cystic fibrosis patients with the G551D mutation.
    Comer DM; Ennis M; McDowell C; Beattie D; Rendall J; Hall V; Elborn JS
    QJM; 2009 Nov; 102(11):793-8. PubMed ID: 19734299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.